BSE filing, NSE: ASTAR. Summary written from the filing by ALFA Finder's alert engine.
Asian Star Company Ltd: key numbers
- Share price
- ₹626.00
- Market cap
- ₹1,002 Cr
- Revenue (annual)
- ₹2,882 Cr
- Net profit (annual)
- ₹40.42 Cr
- P/E (TTM)
- 30.9×Sector 49.5×
- Promoter holding
- 74.66%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Asian Star Company Ltd
All →Asian Star Company Board Meeting Date
Asian Star Company Ltd scheduled a board meeting on 4 November 2026 to consider half-year unaudited financial results. No decisions have been taken yet; the agenda is proposed only.
Asian Star Company Credit Rating
Asian Star Company Limited received a reaffirmed credit rating (CARE A-; Stable/CARE A2+) with the outlook revised to 'Stable' by CARE Ratings.
Asian Star Company Annual General Meeting
Asian Star Company Ltd held its 32nd Annual General Meeting on September 28, 2026. The meeting covered financial adoption, dividend declaration, and re-appointment of directors.
Asian Star Company Price Movement Clarification
Asian Star Company Ltd told BSE the price movement is purely market-driven. The company confirmed Reg 30 LODR compliance and no withheld material information.
Asian Star Company Management Change
Asian Star announces Independent Director Bijayananda Pattanayak resigned effective September 8, 2026. He also ceases from the Nomination and Remuneration Committee citing other professional commitments.
Asian Star Company Other Announcement
Asian Star Company has sent a letter to shareholders whose email addresses are unregistered, providing a web-link to access the Annual Report 2025-26.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.